what's glp-1 for Weight Loss and Diabetes Indications for GLP-1/GIP RA Summary

After 48 h, hybrid 24 and semaglutide were still active while exenatide and liraglutide showed no more significant activity

At treatment initiation, the median BMI was 34.9 kg/m 2 (IQR: 32.038.6) and the median %EWL was 40.6% (IQR: 27.952.7)

In line with this notion, GIPR is expressed in the hypothalamus and hindbrain 54,61,62,67,68 , and a single 3 rd ventricle bolus injection of GIP is sufficient to decrease body weight and food intake in diet-induced obese mice 54

Our take: Food retailers need to adapt to GLP-1 users changing buying habits

GLP-1 myths Misconceptions still abound with GLP-1 medications

95% CI, 0.66-0.93), and when analyzed in mortality due to any cause, it was also lower in the liraglutide group with a reduction of the RR by 15%